What's new

[Cyprus Times] The EMA does not rule out the emergence of a new variant of coronavirus this winter

koronoiosdfg.jpg

The Agency reiterates that vaccines "protect against serious illness and death."

New variants of the SARS-CoV-2 coronavirus may emerge this winter, but existing vaccines should protect the population from severe forms of the disease, the European Medicines Agency(EMA) announced today.

The heads of this European agency held a press conference on the situation surrounding the Covid-19 pandemic, as the European Union prepares to launch a booster vaccination campaign ahead of winter. That campaign will be with the adapted vaccines, which the EMA approved on Thursday and target the now-dominant Omicron variant. The first vaccines developed to tackle the original strain of the virus, which was first identified in China in 2019, will also be used.

People "should not wait for a specific vaccine," said the EMA's head of vaccine strategy, Marco Cavalleri. "A brand new variant could appear, which we are not in a position to predict today," he added."

The EMA on Thursday approved vaccines from Pfizer/BioNTech and Moderna that target the Omicron BA.1 sub-variant, as well as the original strain. Another Pfizer vaccine targeting the BA.4 and BA.5 subvariants of Omicron is expected to be approved in mid-September. Moderna is also preparing a similar vaccine.

These customized vaccines will primarily target the most vulnerable groups in the population, such as the elderly, pregnant women and health care workers, Cavalleri said. Most other people will receive the original vaccines, "which are able to protect against the severe form of Covid-19 and death," though they are not as effective in preventing infection, he explained.

Source: Cyprus Times


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top